Spherix Global Insights Builds on Respiratory Research Portfolio to Support Continued Growth and Broader Indication Coverage

Positive

AI Analysis

Summary

Spherix Global Insights announced the establishment of its Respiratory Franchise, consolidating its research efforts across asthma, COPD, and ILD with plans to expand into additional respiratory indications.

Importance:2/10

Sentiment:

0.30

respiratoryasthmaCOPDinterstitial lung diseaseresearch expansionmarket intelligence

Related Companies

$GBCYD

Read the original article

Published by GlobeNewswire Clinical Studies on September 21, 2026 6:20 PM

Read Original